MétaCan
Menu
Back to cohort
Record W4403834987 · doi:10.1681/asn.2024y9m6efqk

Evaluating the Clinical, Socioeconomic, and Environmental Impact of Guideline-Directed Therapy in the United States: An IMPACT CKD Analysis

2024· article· en· W4403834987 on OpenAlexaff
Navdeep Tangri, Cole Wyman, Naveen Rao, Jieling Chen, Stacey Priest, Stephen Brown, Aleix Cases, Steven J. Chadban

Bibliographic record

VenueJournal of the American Society of Nephrology · 2024
Typearticle
Languageen
FieldHealth Professions
TopicHealthcare cost, quality, practices
Canadian institutionsEVERSANA (Canada)University of Manitoba
Fundersnot available
KeywordsGuidelineSocioeconomic statusMedicineIntensive care medicineEnvironmental healthPathologyPopulation

Abstract

fetched live from OpenAlex

Background: Chronic kidney disease (CKD) is underdiagnosed and undertreated in the United States (US) despite evidence that therapies can delay disease progression and reduce clinical events. This study aims to illustrate the impact of improved adherence to therapies recommended for patients with CKD (i.e., guideline-directed medical therapy [GDMT]) on clinical, socioeconomic, and environmental outcomes to inform policy decisions. Methods: The US population was simulated for 25-years (baseline: 2022; simulated years: 2023-2047) using the IMPACT CKD model. Two scenarios were compared: 75% adherence to GDMT vs. current practice as observed. GDMT included glucose and lipid lowering, antihypertensive, and lifestyle interventions. It was assumed that patients diagnosed with CKD could be treated with multiple therapies per guideline eligibility and that there would be no changes to guidelines or CKD detection rate over the time horizon. Treatment effects on estimated glomerular filtration rate (eGFR) decline, cardiovascular events, and acute kidney injury (AKI) events were assumed to be multiplicative. Results: Improved adherence to GDMT was associated with a 32% decrease in dialysis due to delayed disease progression. Reductions were projected in myocardial infarction, stroke, hospitalized heart failure, AKI, and death by 21%, 17%, 24%, 9%, and 5%, respectively. Renal replacement therapy (RRT) and total CKD costs were projected to decrease by 25% and 5%, respectively. Freshwater consumption, fossil fuel depletion, and carbon emissions due to RRT were also projected to decrease by 28%. Furthermore, reductions in disease progression and death also contributed to improvements in projected net workdays, gross domestic product, full-time equivalents, and tax revenue among employed patients and caregivers. The benefits of improved adherence to GDMT were seen after six years. Similar trends were observed with a 10-year time horizon but with smaller magnitude. Conclusion: This study predicted significant clinical, socioeconomic, and environmental benefits with improved adherence to GDMT. These findings underscore the importance of policy action to improve adherence and actualize the potential of effective therapies to mitigate CKD burden. Funding: Commercial Support - AstraZeneca

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.007
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.098
Threshold uncertainty score0.195

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.007
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.526
GPT teacher head0.631
Teacher spread0.104 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the American Society of NephrologySame topicHealthcare cost, quality, practicesFrench-language works237,207